
### [MONDO:0016345](http://purl.obolibrary.org/obo/MONDO_0016345)
**Label:** non-familial restrictive cardiomyopathy

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0019439](http://purl.obolibrary.org/obo/MONDO_0019439) (AA amyloidosis), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0017833](http://purl.obolibrary.org/obo/MONDO_0017833) (primary hypereosinophilic syndrome), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0019159](http://purl.obolibrary.org/obo/MONDO_0019159) (Loeffler endocarditis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0019158](http://purl.obolibrary.org/obo/MONDO_0019158) (tropical endomyocardial fibrosis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0017817](http://purl.obolibrary.org/obo/MONDO_0017817) (primary localized amyloidosis), [MONDO:0017816](http://purl.obolibrary.org/obo/MONDO_0017816) (primary systemic amyloidosis), [MONDO:0011895](http://purl.obolibrary.org/obo/MONDO_0011895) (idiopathic hypereosinophilic syndrome), [MONDO:0017835](http://purl.obolibrary.org/obo/MONDO_0017835) (lymphocytic hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0016356](http://purl.obolibrary.org/obo/MONDO_0016356) (diffuse cutaneous systemic sclerosis), [MONDO:0016359](http://purl.obolibrary.org/obo/MONDO_0016359) (limited systemic sclerosis), [MONDO:0018018](http://purl.obolibrary.org/obo/MONDO_0018018) (wild type ATTR amyloidosis), [MONDO:0016358](http://purl.obolibrary.org/obo/MONDO_0016358) (limited cutaneous systemic sclerosis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0019122](http://purl.obolibrary.org/obo/MONDO_0019122) (idiopathic acute eosinophilic pneumonia), [MONDO:0009169](http://purl.obolibrary.org/obo/MONDO_0009169) (endocardial fibroelastosis), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019563](http://purl.obolibrary.org/obo/MONDO_0019563) (crest syndrome), [MONDO:0004803](http://purl.obolibrary.org/obo/MONDO_0004803) (disseminated eosinophilic collagen disease), [MONDO:0004802](http://purl.obolibrary.org/obo/MONDO_0004802) (pulmonary eosinophilia), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0004941](http://purl.obolibrary.org/obo/MONDO_0004941) (eosinophilia-myalgia syndrome), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), 

**Mapped go classes:** [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0061047](http://purl.obolibrary.org/obo/GO_0061047) (positive regulation of branching involved in lung morphogenesis), [GO:0035790](http://purl.obolibrary.org/obo/GO_0035790) (platelet-derived growth factor receptor-alpha signaling pathway), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0001553](http://purl.obolibrary.org/obo/GO_0001553) (luteinization), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0010544](http://purl.obolibrary.org/obo/GO_0010544) (negative regulation of platelet activation), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0008210](http://purl.obolibrary.org/obo/GO_0008210) (estrogen metabolic process), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0003261](http://purl.obolibrary.org/obo/GO_0003261) (cardiac muscle progenitor cell migration to the midline involved in heart field formation), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0050920](http://purl.obolibrary.org/obo/GO_0050920) (regulation of chemotaxis), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0042475](http://purl.obolibrary.org/obo/GO_0042475) (odontogenesis of dentin-containing tooth), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:2000739](http://purl.obolibrary.org/obo/GO_2000739) (regulation of mesenchymal stem cell differentiation), [GO:0071230](http://purl.obolibrary.org/obo/GO_0071230) (cellular response to amino acid stimulus), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005021](http://purl.obolibrary.org/obo/GO_0005021) (vascular endothelial growth factor-activated receptor activity), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0005018](http://purl.obolibrary.org/obo/GO_0005018) (platelet-derived growth factor alpha-receptor activity), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation) 51.52%
- [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth) 51.52%
- [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation) 51.52%
- [GO:0030539](http://purl.obolibrary.org/obo/GO_0030539) (male genitalia development) 51.52%
- [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development) 51.52%
- [GO:0003261](http://purl.obolibrary.org/obo/GO_0003261) (cardiac muscle progenitor cell migration to the midline involved in heart field formation) 51.52%
- [GO:0001553](http://purl.obolibrary.org/obo/GO_0001553) (luteinization) 51.52%
- [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development) and [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development) 51.52%
- [GO:0048731](http://purl.obolibrary.org/obo/GO_0048731) (system development) and [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development) 51.52%
- [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation) 36.87%
- [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development) 36.87%
- [GO:0034109](http://purl.obolibrary.org/obo/GO_0034109) (homotypic cell-cell adhesion) 36.87%
- [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development) 36.87%
- [GO:0003260](http://purl.obolibrary.org/obo/GO_0003260) (cardioblast migration) 36.87%


